Lessons Learned from Clinical Trials in Acute Heart Failure: Phase 3 Drug Trials

被引：3
|
作者：
O'Connor, Christopher M. [1 ]
Fiuzat, Mona [1 ]
机构：
[1] Duke Univ, Med Ctr, Div Cardiol, Durham, NC 27710 USA
来源：
HEART FAILURE CLINICS | 2011年 / 7卷 / 04期
关键词：
Acute heart failure; Phase 3 clinical trials; Endpoints; Efficacy; Safety; RANDOMIZED CONTROLLED-TRIAL; ANTAGONIST; ROLOFYLLINE; NESIRITIDE;
D O I：
10.1016/j.hfc.2011.06.013
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Phase 3 clinical trials in acute heart failure are conducted to allow safety and efficacy data to be collected for the evaluation of treatment strategies, including drugs, devices, diagnostics, or nonpharmacological interventions. There are several important features regarding the conduct of phase 3 clinical trials in acute heart failure. This article describes in detail these important aspects of conducting phase 3 clinical trials in an acute heart failure population.
引用
收藏
页码：451 / +
页数：7
相关论文
共 50 条
  • [41] Role of Turmeric and Curcumin in Prevention and Treatment of Chronic Diseases: Lessons Learned from Clinical Trials
    Kunnumakkara, Ajaikumar B.
    Hegde, Mangala
    Parama, Dey
    Girisa, Sosmitha
    Kumar, Aviral
    Daimary, Uzini Devi
    Garodia, Prachi
    Yenisetti, Sarat Chandra
    V. Oommen, Oommen
    Aggarwal, Bharat B.
    ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2023, 6 (04) : 447 - 518
  • [42] Prevention of sporadic Alzheimer's disease: lessons learned from clinical trials and future directions
    Andrieu, Sandrine
    Coley, Nicola
    Lovestone, Simon
    Aisen, Paul S.
    Vellas, Bruno
    LANCET NEUROLOGY, 2015, 14 (09) : 926 - 944
  • [43] Efficacy of Nondiuretic Pharmacotherapy for Improving the Treatment of Congestion in Patients with Acute Heart Failure: A Systematic Review of Randomised Controlled Trials
    Emara, Abdelrahman N.
    Mansour, Noha O.
    Elnaem, Mohamed Hassan
    Wadie, Moheb
    Dehele, Inderpal Singh
    Shams, Mohamed E. E.
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (11)
  • [44] Lessons Learned and Recommendations from a SCOPE Spinal Cord Injury Neurorestorative Clinical Trials Update
    Kondiles, Bethany R.
    Rana, Sabhya
    Weiner, David
    Blesch, Armin
    St John, James
    Haag-Molkenteller, Cornelia
    Freund, Patrick
    Guest, James
    Mikol, Daniel D.
    Harkema, Susan
    Trumbower, Randy D.
    Fehlings, Michael G.
    Weidner, Norbert
    Hogge, Gary S.
    Field-Fote, Edelle C.
    Baptista, Marco A. S.
    Curt, Armin
    Hsieh, Jane
    Jones, Linda
    NEUROTRAUMA REPORTS, 2025, 6 (01): : 210 - 231
  • [45] Sacubitril/valsartan in heart failure: efficacy and safety in and outside clinical trials
    Abdin, Amr
    Schulz, Martin
    Riemer, Uwe
    Haderi, Bledar
    Wachter, Rolf
    Laufs, Ulrich
    Bauersachs, Johann
    Kindermann, Ingrid
    Boehm, Michael
    ESC HEART FAILURE, 2022, 9 (06): : 3737 - 3750
  • [46] The challenges and lessons learned in conducting clinical trials in pregnant women with antiphospholipid syndrome
    Skeith, Leslie
    Bates, Shannon M.
    Bates, Veronica
    Rodger, Marc A.
    THROMBOSIS RESEARCH, 2020, 194 : 54 - 56
  • [47] Pragmatic clinical trials for localized prostate cancer: lessons learned and "three sins"
    Roach III, Mack
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [48] Clinical development of bempedoic acid: phase 2 and phase 3 clinical trials
    Lekuona, Inaki
    Pinto, Xavier
    CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2021, 33 : 58 - 64
  • [49] Determinants of Diuretic Responsiveness and Associated Outcomes During Acute Heart Failure Hospitalization: An Analysis From the NHLBI Heart Failure Network Clinical Trials
    Kiernan, Michael S.
    Stevens, Susanna R.
    Tang, W. H. Wilson
    Butler, Javed
    Anstrom, Kevin J.
    Birati, Edo Y.
    Grodin, Justin L.
    Gupta, Divya
    Margulies, Kenneth B.
    Larue, Shane
    Davila-Roman, Victor G.
    Hernandez, Adrian F.
    De Las Fuentes, Lisa
    JOURNAL OF CARDIAC FAILURE, 2018, 24 (07) : 428 - 438
  • [50] An evaluation of the FDA Responder Endpoint for IBS-C clinical trials: analysis of data from linaclotide Phase 3 clinical trials
    Macdougall, J. E.
    Johnston, J. M.
    Lavins, B. J.
    Nelson, L. M.
    Williams, V. S. L.
    Carson, R. T.
    Shiff, S. J.
    Shi, K.
    Kurtz, C. B.
    Baird, M. J.
    Currie, M. G.
    Lembo, A. J.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2013, 25 (06) : 481 - e365
12345